Introduction to Animal Models of Trigeminal Neuralgia

The trigeminal neuralgia animal model is a classic neuropathic pain model used to replicate the paroxysmal, severe pain experienced in the human trigeminal nerve–innervated region. It is primarily established through surgical compression, chronic constriction, or inflammatory stimulation, such as trigeminal root ligation, vascular compression, or local irritation with formalin or inflammatory mediators. Following model induction, animals typically exhibit behavioral changes including abnormal facial tactile sensitivity, markedly heightened mechanical allodynia, and hyperalgesia, accompanied by pathological alterations like aberrant neuronal firing in the trigeminal ganglion, demyelination of nerve fibers, and localized inflammatory responses. This model is widely employed in studies of the mechanisms underlying neuropathic pain and in the screening and evaluation of analgesic agents.

Service Advantages of Aniphe BioLab’s Trigeminal Neuralgia Animal Model Platform

The Aniphe BioLab Trigeminal Neuralgia Animal Model Platform centers on the precise induction of nerve injury and the robust reconstruction of a stable facial neuropathic pain phenotype, providing a reliable in vivo evaluation system for analgesic drug development and research into the pathophysiological mechanisms of trigeminal neuralgia.

	Enhance through multiple modeling approaches. It supports mainstream modeling approaches, including trigeminal nerve root compression, vascular compression, and inflammation‑induced mechanisms, and is adaptable to diverse research directions.
	Precise and controllable lesion localization By performing microsurgical procedures to precisely target the relevant branches or root segments of the trigeminal nerve, model consistency is improved.
	The model exhibits high reproducibility. Standardized surgical protocols and positioning systems minimize inter‑individual variability, ensuring the stability of pain‑related behavioral data.
	Neuropathological changes are well-defined. It allows for the observation of key pathological processes, including demyelination of nerve fibers, abnormal electrical discharges, and localized inflammatory responses.
	Multidimensional Behavioral Assessment By integrating facial tactile threshold testing with behavioral pain analysis, a systematic pain assessment can be achieved.
	Adaptation Mechanisms and Pharmacological Efficacy Studies It supports both analgesic drug screening and the investigation of the pathogenic mechanisms underlying trigeminal neuralgia.

Modeling cycle	6–14 weeks
Laboratory animals	Male SD rats or Wistar rats
Positive drug	Carbamazepine (a sodium channel blocker and first-line treatment for trigeminal neuralgia), gabapentin, pregabalin, oxcarbazepine, as well as morphine and duloxetine, were used to validate the predictive validity of the model.
Application areas	Pathogenesis of trigeminal neuralgia (peripheral sensitization, central sensitization, and glial–neuronal interactions); screening of novel analgesic agents targeting sodium channels, calcium channels, and TRP channels; investigation into neuropathic pain and the inflammatory regulation of the trigeminal ganglion; and preclinical evaluation of nonpharmacological interventions such as nerve‑encapsulating materials and pulsed radiofrequency.

Construction of an Animal Model of Trigeminal Neuralgia

In the chronic infraorbital nerve compression model, after anesthetizing the animal, the infraorbital nerve is exposed, and mild, sustained compression is applied using a microsuture or a silicone tube, maintaining a low‑intensity injury over an extended period to induce abnormal neuronal firing and pain sensitization. In contrast, the inflammation‑induced model involves local injection of inflammatory agents—such as formalin or complete Freund’s adjuvant—into the trigeminal nerve–innervated region or around the nerve trunk, thereby triggering a localized inflammatory response that increases neuronal excitability and lowers the pain threshold.

Both models consistently reproduce facial mechanical allodynia, hyperalgesia, and spontaneous pain behaviors, accompanied by nerve fiber damage, demyelination, and upregulation of inflammatory mediators, making them widely used approaches for investigating the mechanisms of trigeminal neuralgia and evaluating analgesic agents.